Geovax Labs Stock (NASDAQ: GOVX) stock price, news, charts, stock research, profile.
Open | $1.470 |
Close | - |
Volume / Avg. | 35.784K / 52.707K |
Day Range | 1.400 - 1.630 |
52 Wk Range | 0.250 - 11.537 |
Market Cap | $3.416M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 0.29% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 8.00 expecting GOVX to rise to within 12 months (a possible 471.43% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Geovax Labs (NASDAQ: GOVX) is $1.4 last updated Today at April 26, 2024 at 2:48 PM EDT.
There are no upcoming dividends for Geovax Labs.
Geovax Labs’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.